Market Overview
According to MarketGenics, the global AI-based Pathology Market was valued at USD 0.1 billion in 2025 and is projected to reach USD 0.8 billion by 2035, registering a CAGR of 21.6% during the forecast period of 2026–2035. The market is expanding as healthcare providers increasingly adopt artificial intelligence and digital pathology solutions to improve diagnostic accuracy, accelerate disease detection, and optimize laboratory workflows. AI-based pathology technologies analyze digitized tissue samples and whole-slide images to identify abnormalities, classify diseases, assess biomarkers, and support clinical decision-making. The cancer diagnosis segment accounts for approximately 39% of the market, driven by the growing global cancer burden and rising demand for precision oncology. Increasing adoption of cloud-based pathology platforms, automated image analysis, and AI-assisted diagnostics is creating significant growth opportunities.
To obtain a free sample research report - https://marketgenics.co/download-report-sample/ai-based-pathology-market-12418
Market Growth Drivers
The market is driven by the rising prevalence of cancer and other complex diseases, increasing demand for faster diagnostic results, and the growing adoption of digital pathology infrastructure. Healthcare organizations are implementing AI-powered image analysis, automated tissue classification, biomarker detection, and predictive diagnostic tools to improve efficiency and reduce variability in pathology interpretation. The shortage of qualified pathologists and increasing diagnostic workloads are further encouraging laboratories to adopt AI-enabled solutions. In addition, integration of pathology images with genomic, radiology, and clinical data is supporting precision medicine and personalized treatment planning. Growing investments in cloud-based laboratory platforms, computational pathology, and AI-powered clinical decision-support systems are expected to create further market opportunities.
Key Players
Major companies operating in the global AI-based Pathology Market include F. Hoffmann-La Roche Ltd., Leica Biosystems Nussloch GmbH, Koninklijke Philips N.V., Siemens Healthineers AG, Hamamatsu Photonics K.K., Aiforia Technologies Plc, Hologic, Inc., Indica Labs, Inc., Nucleai Ltd., PathAI, Inc., Proscia Inc., Tempus AI, Inc., and Visiopharm A/S. These companies are focusing on AI-powered image analysis, whole-slide imaging, digital pathology software, workflow automation, and precision oncology solutions. Strategic collaborations, research investments, and the development of integrated diagnostic platforms are strengthening competition in the market.
Regional Insights
North America leads the global AI-based Pathology Market, supported by advanced healthcare infrastructure, widespread adoption of digital pathology, strong investment in AI-driven diagnostics, and growing demand for precision cancer diagnosis. The presence of leading technology developers, diagnostic companies, and research institutions further supports market expansion. Asia Pacific is experiencing rapid growth due to increasing investments in digital healthcare, expanding cancer screening programs, modernization of pathology laboratories, and rising demand for diagnostic services. Countries such as China, India, Japan, and South Korea are creating opportunities through AI adoption, digital laboratory infrastructure, and efforts to address pathologist shortages. Europe also presents opportunities through digital pathology adoption, precision oncology programs, and collaboration between healthcare institutions and technology companies.
Related Reports
Digital Product Passport Solutions Market
Deepfake Detection Technology Market
Decentralized Identity Solutions Market
Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email:
sales@marketgenics.co